Skip to main content
. 2013 Apr 17;6:153. doi: 10.1186/1756-0500-6-153

Table 5.

Logistic regression model of the odds ratio of the EACS Guidelines Unlisted regimens in 333 HIV/HBV co-infected patients currently on anti-HBV treatment

Characteristics EACS GU regimens adjusted OR
 
(95% CI) P
N. enrolled per center§
 
 
≥20 patients
0.56 (0.23-1.37)
0.2
Female gender
1.92 (0.71-5.18)
0.2
Immigrant status
 
 
Foreign birth
1.4 (0.71-2.74)
0.33
Age at diagnosis
 
 
10 years increase
1.23 (1.02-1.48)
0.03
Years since diagnosis*
 
0.12
2-10
0.68 (0.24-1.9)
<10
1.08 (0.39-3.04)
Alcohol consumption
 
 
Ever
2.21 (0.84-5.86)
0.11
Disease stage°
 
 
Cirrhosis/HCC
1.57 (0.75-3.29)
0.23
HBeAg
 
 
Positivity
0.83 (0.44-1.55)
0.56
HCV co-infection
 
 
Yes
2.74 (1.39-5.41)
0.004
HDV co-infection
 
 
Yes
0.41 (0.18-0.93)
0.03
Previous treatment
 
 
Yes 0.4 (0.19-0.83) 0.01

Reference: § = ≤20 patients enrolled; * = <2 years;° = chronic hepatitis. EACS, European AIDS Clinical Society; OR, odds ratio; CI, confidence interval; HCC, hepatocellular carcinoma.